Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. The company is headquartered in Bethesda, Maryland and currently employs 25 full-time employees. The company went IPO on 2001-12-14. The firm is focused on developing personalized immune therapies for cancer. The company has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The firm's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. The company has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, Northwest Biotherapeutics Capital Limited, Northwest Biotherapeutics B.V., Advent BioServices Ltd., and others.
NWBO stock price ended at $0.29 on Mardi, after dropping 3.33%
On the latest trading day Jan 20, 2026, the stock price of NWBO fell by 3.33%, dropping from $0.31 to $0.29. During the session, the stock saw a volatility of 10.71%, with prices oscillating between a daily low of $0.28 and a high of $0.31. On the latest trading day, the trading volume for NWBO decreased by 472.4K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 2.8M shares were traded, with a market value of approximately $443.3M.
Signaux Techniques de NWBO
Résumé des Signaux Techniques
Acheter des signaux 5
Signaux neutres 2
Signaux de vente 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
NWBO présente actuellement 5 signaux d'achat et 0 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -3.33% pendant cette période. En général, les indicateurs techniques indiquent une tendance Strong Buy à moyen terme.
Signaux haussiers/baissiers pour NWBO
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour NWBO, vous aidant à prendre des décisions d'investissement éclairées.
Questions complémentaires
Comment les indicateurs d'analyse technique s'appliquent-ils à NWBO ?
Quels sont les niveaux de retracement de Fibonacci pour NWBO ?
Quel est le RSI de Northwest Biotherapeutics Inc ?
Quel est le prix de Northwest Biotherapeutics Inc pour les 12 prochains mois ?